Come up with a name for your new list and we'll add to it:
Arisaph Pharmaceuticals raised a round of funding on August 14, 2006. Investors include
Vatera Healthcare Partners.
Arisaph Pharmaceuticals, formerly Triad Pharmaceuticals, is an emerging biopharmaceutical company focused on developing therapies for cancer, cardiovascular disease and diabetes. The company utilizes …